2015

CapeBio™ Initiative

CapeBio™ Initiative is conceptualized and initiated at Council for Scientific and Industrial Research (CSIR) – with the support from Department of Science and Innovation (DSI).

2015

CapeBio™ Initiative

2016

CapeExpress™ DNA ligase

The first flagship product (CapeExpress™ DNA ligase) is launched for market testing. The product is distributed to researchers across South Africa for evaluation and feedback.

2016

CapeExpress™ DNA ligase

2017

CapeSprint™ Taq DNA Polymerase

The second flagship product (CapeSprint™ Taq DNA polymerase) enters a market testing phase. It was distributed to the researchers across South Africa, Southern, Western and Eastern Africa.

2017

CapeSprint™ Taq DNA Polymerase

2018

CapeHi-Fidelity™ and Pty (Ltd) Registered

The third product (CapeHi-Fidelity™ Pfu DNA polymerase) enters the market testing phase and distributed to researchers for evaluations and feedback. And CapeBio™ Technologies (Pty) Ltd is officially registered as a private entity.

2018

CapeHi-Fidelity™ and Pty (Ltd) Registered

2019

Funding, Partnerships and Awards

We raised funding with E2 Investments and officially launched the products in the market. While winning 3rd Prize Award at the Africa Start-up Gate Summit in Tunisia and 1st Prize Award in partnership with ARC at the South African Innovation Bridge sponsored by Department of Science and Innovation, Technology Innovation Agency, SEDA and KISCH IP.

2019

Funding, Partnerships and Awards

2020

COVID-19 RT-qPCR test kit

CapeBio™ develops COVID-19 RT-qPCR test kit and associated reagents.

2020

COVID-19 RT-qPCR test kit

2021

Proprietary AI Platform Development Launch

CapeBio™ develops and launches its proprietary AI and machine learning platform for development of "best-in-class" biomolecules for wide range of life science industrial applications.

2021

Proprietary AI Platform Development Launch

Scroll to Top